Physician

Priya Mahindra Nayyar, M.D.

According to 2025 Medicare claims, Priya Nayyar, M.D. (NPI: 1649407719) practices dermatology in the St. Petersburg-Clearwater-Largo, FL market, with the plurality of this provider's patient population coming from Pinellas, FL. This provider's primary affiliated billing organization is PREMIER DERMATOLOGY, LLC (NPI: 1700202298; TIN: 46-3596468) and primary practice location at 33704-2034.

Nayyar's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,072 traditional Medicare patients, billed 10,550 HCPCS/CPT codes, and received $3,676,140 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 274 prescription claims across 161 beneficiaries totaling $12,871 in drug costs, led by Mupirocin (Mupirocin). Open Payments data shows 25 records totaling $902. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $42,961 to $3,676,140. In contrast, Part D prescription costs started with an early spike, then settled into a lower baseline, moving from $59,911 to $12,871. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.7M2015 Medicare payment: $42,961 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $203,212 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $308,679 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $442,929 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $120,458 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $173,114 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $484,818 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $540,627 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $969,632 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,676,140 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015149439$42,961
2016262825$203,212
20173671,313$308,679
20184941,927$442,929
2019160504$120,458
2020194935$173,114
20216493,238$484,818
20226793,497$540,627
20239116,247$969,632
20241,07210,550$3,676,140

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$30K$60K2015 Drug cost: $59,911 (USD; Tot_Drug_Cst)2016 Drug cost: $25,309 (USD; Tot_Drug_Cst)2017 Drug cost: $4,719 (USD; Tot_Drug_Cst)2018 Drug cost: $5,255 (USD; Tot_Drug_Cst)2019 Drug cost: $1,059 (USD; Tot_Drug_Cst)2020 Drug cost: $10,385 (USD; Tot_Drug_Cst)2021 Drug cost: $16,806 (USD; Tot_Drug_Cst)2022 Drug cost: $18,963 (USD; Tot_Drug_Cst)2023 Drug cost: $18,101 (USD; Tot_Drug_Cst)2024 Drug cost: $12,871 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201592280$59,911
201682147$25,309
2017131198$4,719
2018125181$5,255
20194058$1,059
202066141$10,385
2021184381$16,806
2022198379$18,963
2023162289$18,101
2024161274$12,871

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17311Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks303352$482
11102Biopsy of related skin growth, first growth331443$69
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more554898$67
17000Destruction of precancer skin growth, 1 growth403570$39
17003Destruction of precancer skin growth, 2-14 growths3101,939$5

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
MupirocinMupirocin911,912$632
CephalexinCephalexin50324$302
DutasterideDutasteride171,007$281
Triamcinolone AcetonideTriamcinolone Acetonide14326$145
Doxycycline HyclateDoxycycline Hyclate11142$77

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.25$902Organogenesis Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Priya Mahindra Nayyar, M.D.?

Tedicare shows public-source Medicare data for Priya Mahindra Nayyar, M.D. (NPI 1649407719), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Priya Mahindra Nayyar, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Priya Mahindra Nayyar, M.D.?

Priya Mahindra Nayyar, M.D. is linked to PREMIER DERMATOLOGY, LLC (billing NPI 1700202298) in the available physician profile data.

Does Priya Mahindra Nayyar, M.D. have Open Payments data?

Priya Mahindra Nayyar, M.D. has 25 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.